Log In
Print
BCIQ
Print
Print this Print this
 

AVN-211

  Manage Alerts
Collapse Summary General Information
Company Avineuro Pharmaceuticals Inc.
DescriptionSmall molecule serotonin (5-HT6) receptor antagonist
Molecular Target Serotonin (5-HT6) receptor
Mechanism of ActionSerotonin (5-HT6) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation

Partner

AllaChem LLC


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today